HM Payson & Co’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$20.3K 1158
2025
Q4
$20.3K Hold
200
﹤0.01% 834
2025
Q3
$10.9K Hold
200
﹤0.01% 895
2025
Q2
$10.6K Hold
200
﹤0.01% 849
2025
Q1
$8.66K Hold
200
﹤0.01% 870
2024
Q4
$11.2K Hold
200
﹤0.01% 831
2024
Q3
$13.6K Sell
200
-435
-69% -$24.6K ﹤0.01% 813
2024
Q2
$26.8K Buy
635
+435
+218% +$23.9K ﹤0.01% 710
2024
Q1
$13.8K Hold
200
﹤0.01% 790
2023
Q4
$14.8K Hold
200
﹤0.01% 781
2023
Q3
$13.6K Hold
200
﹤0.01% 786
2023
Q2
$18.8K Hold
200
﹤0.01% 739
2023
Q1
$13.6K Buy
+200
New +$12.9K ﹤0.01% 769
2022
Q4
Sell
-200
Closed -$6K 957
2022
Q3
$6K Hold
200
﹤0.01% 832
2022
Q2
$8K Hold
200
﹤0.01% 837
2022
Q1
$14K Sell
200
-281
-58% -$20.5K ﹤0.01% 804
2021
Q4
$37K Buy
481
+261
+119% +$23K ﹤0.01% 664
2021
Q3
$21K Hold
220
﹤0.01% 733
2021
Q2
$27K Sell
220
-571
-72% -$68.1K ﹤0.01% 687
2021
Q1
$104K Hold
791
﹤0.01% 475
2020
Q4
$105K Sell
791
-178
-18% -$21.5K ﹤0.01% 468
2020
Q3
$99K Buy
969
+769
+385% +$66.4K ﹤0.01% 452
2020
Q2
$17K Sell
200
-300
-60% -$24K ﹤0.01% 686
2020
Q1
$29K Hold
500
﹤0.01% 580
2019
Q4
$46K Hold
500
﹤0.01% 605
2019
Q3
$45K Hold
500
﹤0.01% 610
2019
Q2
$59K Buy
+500
New +$50.4K ﹤0.01% 574

Other funds holding EXAS

HM Payson & Co's EXAS Position: Q1 2026 in Review

HM Payson & Co sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 200 shares — an estimated $20.3K sold.

HM Payson & Co first reported a position in EXAS in Q2 2019 and held it in 26 quarters. The position peaked at $105K in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HM Payson & Co reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HM Payson & Co sold 200 Exact Sciences shares in Q1 2026, an estimated $20.3K.
  • HM Payson & Co first reported a position in Exact Sciences in Q2 2019 and held it in 26 quarters.
  • HM Payson & Co's Exact Sciences position peaked at $105K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HM Payson & Co's 13F filing for Q1 2026, filed 13 Apr 2026.